Sabrina Chang, PA
Physician Assistant · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 5 years
- Graduated 2021
Offices
2 locations · University of California San Francisco · 1,780 clinicians in this group
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Sabrina Chang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$5,219
Medicare paid this office $5,219 for 85 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Blood test, thyroid stimulating hormone (tsh) | 28 | $510 | $16 |
| Vitamin d-3 level | 17 | $493 | $29 |
| Blood test, lipids (cholesterol and triglycerides) | 32 | $446 | $13 |
| Insertion of needle into vein for collection of blood sample | 57 | $406 | $6 |
| Blood test, comprehensive group of blood chemicals | 28 | $331 | $10 |
See all 10 services
| Blood test, thyroid stimulating hormone (tsh) | 28 | $510 | $16 |
| Vitamin d-3 level | 17 | $493 | $29 |
| Blood test, lipids (cholesterol and triglycerides) | 32 | $446 | $13 |
| Insertion of needle into vein for collection of blood sample | 57 | $406 | $6 |
| Blood test, comprehensive group of blood chemicals | 28 | $331 | $10 |
| Hemoglobin a1c level | 33 | $314 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 39 | $297 | $8 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 13 | $230 | $18 |
| Blood test, basic group of blood chemicals (calcium, total) | 16 | $149 | $8 |
| Manual urinalysis test with examination using microscope, automated | 18 | $81 | $3 |
Who their Medicare patients are
85 Original Medicare patients in 2024. Average age 72 · Women 56% · Health risk score 0.90. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 56% · Diabetes 16% · Depression 15%.
The office billed $14,859, Medicare allowed $5,219 and paid $5,219; for 397 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 85 | 397 | 72 | 0.90 | $14,859 | $5,219 |
| 2023 | 93 | 474 | 72 | 0.80 | $17,441 | $6,134 |
| 2022 | 61 | 332 | 69 | 0.76 | $11,715 | $3,169 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Blood test, lipids (cholesterol and triglycerides) | 41 | $577 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 33 | $543 | $16 |
| Vitamin d-3 level | 14 | $435 | $29 |
| Insertion of needle into vein for collection of blood sample | 55 | $435 | $6 |
| Blood test, comprehensive group of blood chemicals | 37 | $414 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 45 | $358 | $8 |
| Hemoglobin a1c level | 29 | $314 | $10 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 14 | $248 | $18 |
| Blood test, basic group of blood chemicals (calcium, total) | 19 | $216 | $8 |
| Urine microalbumin (protein) level | 21 | $130 | $6 |
| Creatinine level to test for kidney function or muscle injury | 21 | $117 | $5 |
| Manual urinalysis test with examination using microscope, automated | 16 | $62 | $3 |
2022: 10 services
| Blood test, lipids (cholesterol and triglycerides) | 34 | $459 | $13 |
| Blood test, comprehensive group of blood chemicals | 37 | $404 | $10 |
| Blood test, thyroid stimulating hormone (tsh) | 21 | $362 | $16 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 33 | $282 | $8 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 13 | $230 | $18 |
| Hemoglobin a1c level | 19 | $190 | $10 |
| Insertion of needle into vein for collection of blood sample | 47 | $165 | $3 |
| Urine microalbumin (protein) level | 17 | $96 | $6 |
| Creatinine level to test for kidney function or muscle injury | 17 | $86 | $5 |
| Manual urinalysis test with examination using microscope, automated | 12 | $40 | $3 |
Medicaid work
$482,098 in 2024
Medicaid paid $482,098 for 21,142 billed services this clinician did in 2024, up to 220 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 2,713 | $481,745 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 110 | $131 |
| Short return visit (20+ min) | 2,074 | $111 |
| Short return visit | 2,259 | $71 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 182 | $40 |
| Medication list documented in medical record (COA) | 631 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 369 | $0 |
| BODY MASS INDEX DOCD | 3,287 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 2,830 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 533 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 174 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 2,913 | $0 |
| 2024 | 21,142 | 28 | 220 | $482,098 |
| 2023 | 11,515 | 23 | 239 | $378,158 |
| 2022 | 5,804 | 21 | 189 | $138,760 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,727 | $377,698 |
| Short return visit (20+ min) | 1,637 | $345 |
| Short return visit | 2,131 | $110 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 805 | $5 |
| Medication list documented in medical record (COA) | 76 | $0 |
| BODY MASS INDEX DOCD | 321 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 970 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 236 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 48 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 1,021 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 264 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 79 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,088 | $138,572 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose | 41 | $67 |
| Short return visit | 884 | $54 |
| Short return visit (20+ min) | 776 | $37 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 335 | $25 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 452 | $5 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose | 103 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 505 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 158 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 77 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 621 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 129 | $0 |
Drugs they prescribed that Part D paid
$103,714
Pharmacies billed $103,714 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,073) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
912 generic and 148 brand-name prescriptions · $103,714 in drug cost · 39 antibiotic prescriptions to 29 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 11 | $16,632 | $1,512 |
| Abrysvo | 20 | $5,691 | $285 |
| Atorvastatin | 106 | $1,245 | $12 |
| Telmisartan | 18 | $586 | $33 |
| Albuterol Sulfate Hfa | 16 | $578 | $36 |
See all 23 drugs
| Jardiance | 11 | $16,632 | $1,512 |
| Abrysvo | 20 | $5,691 | $285 |
| Atorvastatin | 106 | $1,245 | $12 |
| Telmisartan | 18 | $586 | $33 |
| Albuterol Sulfate Hfa | 16 | $578 | $36 |
| Amlodipine Besylate | 93 | $578 | $6 |
| Famotidine | 57 | $520 | $9 |
| Tamsulosin | 27 | $494 | $18 |
| Losartan | 39 | $458 | $12 |
| Metoprolol | 18 | $411 | $23 |
| Fluticasone Propionate | 49 | $323 | $7 |
| Valsartan | 12 | $310 | $26 |
| Levothyroxine | 24 | $306 | $13 |
| Metformin Hcl Er | 22 | $267 | $12 |
| Rosuvastatin | 18 | $234 | $13 |
| Metformin | 18 | $222 | $12 |
| Pantoprazole | 16 | $188 | $12 |
| Naproxen | 22 | $170 | $8 |
| Omeprazole | 22 | $133 | $6 |
| Hydrocortisone | 13 | $127 | $10 |
| Procto-Med Hc | 11 | $114 | $10 |
| Triamcinolone Acetonide | 18 | $110 | $6 |
| Hydrochlorothiazide | 20 | $96 | $5 |
Year by year
| 2024 | 1,073 | 238 | 0% (0) | 14% | $103,714 |
| 2023 | 868 | 223 | None | 17% | $97,823 |
| 2022 | 270 | 106 | 0% (0) | None | $16,142 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Jardiance | 19 | $27,177 | $1,430 |
| Incruse Ellipta | 21 | $8,054 | $384 |
| Atorvastatin | 78 | $1,825 | $23 |
| Amlodipine Besylate | 50 | $951 | $19 |
| Ventolin Hfa | 13 | $890 | $68 |
| Ketoconazole | 20 | $768 | $38 |
| Metoprolol | 21 | $656 | $31 |
| Diclofenac | 22 | $538 | $24 |
| Metformin Hcl Er | 20 | $500 | $25 |
| Lisinopril | 25 | $464 | $19 |
| Losartan | 19 | $410 | $22 |
| Fluticasone Propionate | 15 | $334 | $22 |
| Tamsulosin | 12 | $318 | $26 |
| Omeprazole | 23 | $278 | $12 |
| Metformin | 20 | $253 | $13 |
| Hydrochlorothiazide | 17 | $188 | $11 |
| Triamcinolone Acetonide | 15 | $149 | $10 |
| Famotidine | 15 | $148 | $10 |
| Paxlovid (Eua) | 11 | $118 | $11 |
| Ibuprofen | 18 | $92 | $5 |
| Naproxen | 11 | $83 | $8 |
| Meclizine | 13 | $70 | $5 |
| Chlorhexidine Gluconate | 12 | $57 | $5 |
2022: 5 drugs
| Atorvastatin | 16 | $377 | $24 |
| Procto-Med Hc | 14 | $374 | $27 |
| Diclofenac | 15 | $360 | $24 |
| Amlodipine Besylate | 28 | $124 | $4 |
| Lisinopril | 12 | $116 | $10 |
Money from drug and device companies
$700 in 2025
A payment is not proof that care is biased.
| Aurinia Pharma U.S. | Lupkynis | $207 | 8 payments
|
| Alnylam Pharmaceuticals | Givlaari | $102 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $96 | 2 payments
|
| Novartis Pharmaceuticals | Ilaris | $95 | 4 payments
|
| Calliditas Therapeutics US | Tarpeyo | $46 | 2 payments
|
| Fresenius Kabi USA | Idacio | $30 | 1 payment
|
See all 26 published payments
| Calliditas Therapeutics US | Meals · 2025-12-18 | Tarpeyo | $20 |
| Otsuka America Pharmaceutical | Meals · 2025-12-17 | Jynarque | $28 |
| Aurinia Pharma U.S. | Meals · 2025-12-16 | Lupkynis | $29 |
| Amgen | Meals · 2025-12-11 | Tavneos | $27 |
| Aurinia Pharma U.S. | Meals · 2025-11-20 | Lupkynis | $29 |
| Novartis Pharmaceuticals | Meals · 2025-11-18 | Ilaris | $26 |
| Alnylam Pharmaceuticals | Meals · 2025-11-18 | Givlaari | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-05 | Saphnelo | $78 |
| Novartis Pharmaceuticals | Meals · 2025-10-28 | Vanrafia | $21 |
| Sobi | Meals · 2025-10-15 | Kineret | $25 |
| Aurinia Pharma U.S. | Meals · 2025-09-30 | Lupkynis | $26 |
| Alnylam Pharmaceuticals | Meals · 2025-09-22 | Givlaari | $30 |
| Aurinia Pharma U.S. | Meals · 2025-08-16 | Lupkynis | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-12 | Farxiga | $18 |
| Alnylam Pharmaceuticals | Meals · 2025-07-28 | Oxlumo | $25 |
| Aurinia Pharma U.S. | Meals · 2025-07-24 | Lupkynis | $29 |
| Ucb | Meals · 2025-07-11 | Bimzelx | $22 |
| Novartis Pharmaceuticals | Meals · 2025-07-07 | Ilaris | $23 |
| Alnylam Pharmaceuticals | Meals · 2025-06-23 | Oxlumo | $23 |
| Aurinia Pharma U.S. | Meals · 2025-06-19 | Lupkynis | $18 |
| Janssen Biotech | Meals · 2025-06-17 | Tremfya | $23 |
| Novartis Pharmaceuticals | Meals · 2025-06-09 | Fabhalta | $24 |
| Aurinia Pharma U.S. | Meals · 2025-05-08 | Lupkynis | $27 |
| Aurinia Pharma U.S. | Meals · 2025-03-26 | Lupkynis | $27 |
| Calliditas Therapeutics US | Meals · 2025-03-13 | Tarpeyo | $26 |
| Fresenius Kabi USA | Meals · 2025-02-20 | Idacio | $30 |
Professional record
- NPI
- 1497378970
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 1310 Club Dr, Vallejo, CA, 94592
- NPI first listed
- 2020-05-19
- NPI last updated
- 2022-04-20
- NPI record certified
- 2022-04-20
This is when the NPI record was last certified, not a medical board exam.